3-Factor prothrombin complex concentrate versus 4-factor prothrombin complex concentrate for the reversal of oral factor Xa inhibitors.

Saved in:
Bibliographic Details
Title: 3-Factor prothrombin complex concentrate versus 4-factor prothrombin complex concentrate for the reversal of oral factor Xa inhibitors.
Authors: Hays WB; Department of Pharmacy, Indiana University Health West Hospital, Avon, IN, USA., Billups K; Department of Pharmacy Services, Medical University of South Carolina, Charleston, SC, USA., Nicholson J; Department of Pharmacy, Indiana University Health Adult Academic Medical Center, Indianapolis, IN, USA., Bailey AM; Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, KY, USA., Gregory H; Department of Pharmacy, University of North Carolina Health, Chapel Hill, NC, USA., Weeda ER; Department of Biomedical Sciences, University of South Carolina School of Medicine Greenville, Greenville, SC, USA., Weant KA; Department of Clinical Pharmacy and Outcomes Sciences, College of Pharmacy, University of South Carolina, 715 Sumter Street-CLS 316A, Columbia, SC, 29208, USA. kweant@mailbox.sc.edu.
Source: Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2025 Feb; Vol. 58 (2), pp. 276-283. Date of Electronic Publication: 2024 Oct 28.
Publication Type: Journal Article; Multicenter Study; Comparative Study
Journal Info: Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 9502018 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-742X (Electronic) Linking ISSN: 09295305 NLM ISO Abbreviation: J Thromb Thrombolysis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1573-742X
DOI:10.1007/s11239-024-03052-4